pmprb: why lower drug prices may mean less access
drug pricing policy may sound dry, but even small changes can have a huge impact on people hoping for new treatments.
opinion: stiff price controls will hurt access to ground-breaking drugs
the federal patented medicines price review board thinks companies would be happy to sell canada their new drugs for much less than they get in many other 36 oecd countries. it doesn’t look like they’re right.